Related references
Note: Only part of the references are listed.Safety, Tolerability and Pharmacokinetics of FAAH Inhibitor V158866: A Double-Blind, Randomised, Placebo-Controlled Phase I Study in Healthy Volunteers
Stephen Pawsey et al.
DRUGS IN R&D (2016)
Systematic review of enriched enrolment, randomised withdrawal trial designs in chronic pain: a new framework for design and reporting
R. Andrew Moore et al.
PAIN (2015)
Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjects
Gai Ling Li et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Evaluation of efficacy and safety of gabapentin, duloxetine, and pregabalin in patients with painful diabetic peripheral neuropathy
Padmini Devi et al.
INDIAN JOURNAL OF PHARMACOLOGY (2012)
The Impact of Gabapentin Administration on Brain GABA and Glutamate Concentrations: A 7T 1H-MRS Study
Kejia Cai et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations
Robert H. Dworkin et al.
PAIN (2012)
An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee
John P. Huggins et al.
PAIN (2012)
The Novel Reversible Fatty Acid Amide Hydrolase Inhibitor ST4070 Increases Endocannabinoid Brain Levels and Counteracts Neuropathic Pain in Different Animal Models
Antonio Caprioli et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Pregabalin for Peripheral Neuropathic Pain: A Multicenter, Enriched Enrollment Randomized Withdrawal Placebo-controlled Trial
Ian Gilron et al.
CLINICAL JOURNAL OF PAIN (2011)
Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain
Kay Ahn et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Impact of responder definition on the enriched enrollment randomized withdrawal trial design for establishing proof of concept in neuropathic pain
David J. Hewitt et al.
PAIN (2011)
A comparison between enriched and nonenriched enrollment randomized withdrawal trials of opioids for chronic noncancer pain
Andrea D. Furlan et al.
PAIN RESEARCH & MANAGEMENT (2011)
Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism
Jason R. Clapper et al.
NATURE NEUROSCIENCE (2010)
The efficacy and safety of pregabalin in the treatment of neuropathic pain associated with chronic lumbosacral radiculopathy
Ralf Baron et al.
PAIN (2010)
Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations
Robert H. Dworkin et al.
PAIN (2010)
Neuropathic Pain: A Maladaptive Response of the Nervous System to Damage
Michael Costigan et al.
Annual Review of Neuroscience (2009)
Enriched Enrollment Randomized Withdrawal Trial Designs of Analgesics Focus on Methodology
Nathaniel Katz
CLINICAL JOURNAL OF PAIN (2009)
Efficient assessment of neuropathic pain drugs in patients with small fiber sensory neuropathies
T. W. Ho et al.
PAIN (2009)
Enriched enrolment with randomised withdrawal (EERW): Time for a new look at clinical trial design in chronic pain
Henry J. McQuay et al.
PAIN (2008)
Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): A 6-month, double-blind, placebo-controlled trial with pregabalin
Leslie J. Crofford et al.
PAIN (2008)
Pharmacologic management of neuropathic pain: Evidence-based recommendations
Robert H. Dworkin et al.
PAIN (2007)
Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain
Maulik D. Jhaveri et al.
JOURNAL OF NEUROSCIENCE (2006)
A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain
J. F. Wernicke et al.
NEUROLOGY (2006)
α2δ and the mechanism of action of gabapentin in the treatment of pain
Y. P. Maneuf et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2006)
Painful peripheral neuropathies
P. Marchettini et al.
CURRENT NEUROPHARMACOLOGY (2006)
Algorithm for neuropathic pain treatment: An evidence based proposal
NB Finnerup et al.
PAIN (2005)
A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain
J Raskin et al.
PAIN MEDICINE (2005)
Duloxetine vs. placebo in patients with painful diabetic neuropathy
DJ Goldstein et al.
PAIN (2005)
Advances in neuropathic pain - Diagnosis, mechanisms, and treatment recommendations
RH Dworkin et al.
ARCHIVES OF NEUROLOGY (2003)
Share Paper
